🇧🇷 BONCRESA in Brazil

BONCRESA (DENOSUMAB-MOBZ) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

BONCRESA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in Brazil

Frequently asked questions

Is BONCRESA approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for BONCRESA in Brazil?

AMNEAL PHARMS LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.